Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of multiple sclerosis. However, much more research is warranted to confirm these ...

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS ... in some cases, kidney damage. Anyone with MS who is interested in vitamin D ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with ...

At Baylor Medicine's Maxine Mesinger Multiple Sclerosis Clinic specialized physicians provide diagnostics, treatment and support services to MS patients at a single, easy access location. Our ...

Findings confirmed the approved 600mg IV dose was optimal for slowing disability progression in relapsing MS. A phase 3 study evaluating a higher dose of ocrelizumab in adults with relapsing ...

The new trial is believed to be the first to demonstrate the beneficial effects of vitamin D supplementation for multiple sclerosis ... and potentially lead to kidney and heart damage.